Structural Insights into TOR Signaling
The Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cell...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/8/885 |
id |
doaj-adc5e089570040a78b6b52dd8073d391 |
---|---|
record_format |
Article |
spelling |
doaj-adc5e089570040a78b6b52dd8073d3912020-11-25T03:56:12ZengMDPI AGGenes2073-44252020-08-011188588510.3390/genes11080885Structural Insights into TOR SignalingLucas Tafur0Jennifer Kefauver1Robbie Loewith2Department of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, SwitzerlandDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, SwitzerlandDepartment of Molecular Biology, University of Geneva, 30 quai Ernest-Ansermet, CH1211 Geneva, SwitzerlandThe Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cellular homeostasis and orchestrate the cellular responses to diverse environmental challenges. Interest in understanding TOR signaling is further motivated by observations that link aberrant TOR signaling to a variety of diseases, ranging from epilepsy to cancer. In the last few years, driven in large part by recent advances in cryo-electron microscopy, there has been an explosion of available structures of (m)TORC1 and its regulators, as well as several (m)TORC2 structures, derived from both yeast and mammals. In this review, we highlight and summarize the main findings from these reports and discuss both the fascinating and unexpected molecular biology revealed and how this knowledge will potentially contribute to new therapeutic strategies to manipulate signaling through these clinically relevant pathways.https://www.mdpi.com/2073-4425/11/8/885target of rapamycinstructural biologycell growth homeostasis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lucas Tafur Jennifer Kefauver Robbie Loewith |
spellingShingle |
Lucas Tafur Jennifer Kefauver Robbie Loewith Structural Insights into TOR Signaling Genes target of rapamycin structural biology cell growth homeostasis |
author_facet |
Lucas Tafur Jennifer Kefauver Robbie Loewith |
author_sort |
Lucas Tafur |
title |
Structural Insights into TOR Signaling |
title_short |
Structural Insights into TOR Signaling |
title_full |
Structural Insights into TOR Signaling |
title_fullStr |
Structural Insights into TOR Signaling |
title_full_unstemmed |
Structural Insights into TOR Signaling |
title_sort |
structural insights into tor signaling |
publisher |
MDPI AG |
series |
Genes |
issn |
2073-4425 |
publishDate |
2020-08-01 |
description |
The Target of Rapamycin (TOR) is a highly conserved serine/threonine protein kinase that performs essential roles in the control of cellular growth and metabolism. TOR acts in two distinct multiprotein complexes, TORC1 and TORC2 (mTORC1 and mTORC2 in humans), which maintain different aspects of cellular homeostasis and orchestrate the cellular responses to diverse environmental challenges. Interest in understanding TOR signaling is further motivated by observations that link aberrant TOR signaling to a variety of diseases, ranging from epilepsy to cancer. In the last few years, driven in large part by recent advances in cryo-electron microscopy, there has been an explosion of available structures of (m)TORC1 and its regulators, as well as several (m)TORC2 structures, derived from both yeast and mammals. In this review, we highlight and summarize the main findings from these reports and discuss both the fascinating and unexpected molecular biology revealed and how this knowledge will potentially contribute to new therapeutic strategies to manipulate signaling through these clinically relevant pathways. |
topic |
target of rapamycin structural biology cell growth homeostasis |
url |
https://www.mdpi.com/2073-4425/11/8/885 |
work_keys_str_mv |
AT lucastafur structuralinsightsintotorsignaling AT jenniferkefauver structuralinsightsintotorsignaling AT robbieloewith structuralinsightsintotorsignaling |
_version_ |
1724466419826950144 |